Conivaptan for Hyponatremia in the Neurocritical Care Unit

Neurocritical Care

Volumn 11, Issue 1, 2009, Pages 6-13

  Wright, Wendy L ^a   Asbury, William H ^a   Gilmore, Jane L ^a   Samuels, Owen B ^a  

^a EMORY UNIVERSITY HOSPITAL   (United States)

Author keywords

AVP receptor antagonist; Conivaptan; Euvolemic hyponatremia; Hyponatremia; Neurocritical care; SIADH

Indexed keywords

CONIVAPTAN; FLUDROCORTISONE; SODIUM; SODIUM CHLORIDE; BENZAZEPINE DERIVATIVE; VASOPRESSIN RECEPTOR;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; DRUG EFFICACY; DRUG ELIMINATION; DRUG HALF LIFE; DRUG SAFETY; DRUG WITHDRAWAL; FEMALE; HEART ARRHYTHMIA; HUMAN; HYPONATREMIA; HYPOTENSION; INCIDENCE; INJECTION SITE REACTION; INTENSIVE CARE UNIT; MALE; PRIORITY JOURNAL; SIDE EFFECT; THIRST; ADOLESCENT; BLOOD; BLOOD VOLUME; DRUG ANTAGONISM; DRUG EFFECT; DRUG MONITORING; INTENSIVE CARE; METABOLISM; METHODOLOGY; MIDDLE AGED; RETROSPECTIVE STUDY; SCHWARTZ BARTTER SYNDROME;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BENZAZEPINES; BLOOD VOLUME; CRITICAL CARE; DRUG MONITORING; FEMALE; HUMANS; HYPONATREMIA; INAPPROPRIATE ADH SYNDROME; MALE; MIDDLE AGED; RECEPTORS, VASOPRESSIN; RETROSPECTIVE STUDIES; SODIUM; YOUNG ADULT;

EID: 68949087592     PISSN: 15416933     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12028-008-9152-1     Document Type: Article

References (14)

1. HJ Androgué NE Madias 2000 Hyponatremia N Engl J Med 342 1581 9 10.1056/NEJM200005253422107 10.1056/NEJM200005253422107 (Pubitemid 30340505)
2. RH Sterns SM Silver 2006 Brain volume regulation in response to hypo-osmolality and its correction Am J Med 119 S12 6 10.1016/j.amjmed.2006.05. 003 16843080 10.1016/j.amjmed.2006.05.003 1:CAS:528:DC%2BD28XnslWjtb4%3D
3. A Bhardwaj JA Ulatowski 2004 Hypertonic solutions and brain injury Curr Opin Crit Care 10 126 31 10.1097/00075198-200404000-00009 15075723 10.1097/00075198-200404000-00009 (Pubitemid 38519721)
4. MN Diringer AR Zazulia 2006 Hyponatremia in neurologic patients: consequences and approaches to treatment Neurologist 12 3 117 26 10.1097/01.nrl.0000215741.01699.77 16688013 10.1097/01.nrl.0000215741.01699.77 (Pubitemid 43756309)
5. BR Nathan 2007 Cerebral correlates of hyponatremia Neurocrit Care 6 72 8 10.1385/NCC:6:1:72 17356196 10.1385/NCC:6:1:72 1:CAS:528:DC%2BD2sXnsVSktrg%3D (Pubitemid 46424456)
6. D Zeltser S Rosansky H van Rensburg JG Verbalis N Smith for the Conivaptan Study Group 2007 Assessment of the efficacy of intravenous conivaptan in euvolemic and hypervolemic hyponatremia Am J Nephrol 27 447 57 10.1159/000106456 17664863 10.1159/000106456 1:CAS:528:DC%2BD2sXhtVOrtbzO (Pubitemid 47482001)
7. Vaprisol package insert. Deerfield: Astellas Pharma, U.S. Inc.; 2007
8. JG Verbalis 2006 AVP receptor antagonists as aquaretics: review and assessment of clinical data Cleve Clin J Med 73 Suppl 3 S24 33 16970150 10.3949/ccjm.73.Suppl-3.S24
9. BF Palmer 2003 Hyponatremia in patients with central nervous system disease: SIADH versus CSW Trends Endocrinol Metab 14 4 182 7 10.1016/S1043-2760(03)00048-1 12714279 10.1016/S1043-2760(03)00048-1 1:CAS:528:DC%2BD3sXjtFequ74%3D (Pubitemid 36733904)
10. P Gross D Reimann J Henschkowski M Damian 2001 Treatment of severe hyponatremia: conventional and novel aspects J Am Soc Nephrol 12 S10 4 11251026 1:CAS:528:DC%2BD3MXhtlKisr0%3D
11. 2 receptor antagonists J Mol Endocrinol 29 1 9 10.1677/jme.0.0290001 12200224 10.1677/jme.0.0290001 1:CAS:528:DC%2BD38XmvFOhu7w%3D (Pubitemid 34965741)
12. A Bhardwaj 2006 Neurological impact of vasopressin dysregulation and hyponatremia Ann Neurol 59 229 36 10.1002/ana.20788 16437573 10.1002/ana.20788 1:CAS:528:DC%2BD28XhvVSlu7s%3D (Pubitemid 43202475)
13. D Hasan M Vermeulen EF Wijdicks A Hijdra J van Gijn 1989 Effect of fluid intake and antihypertensive treatment on cerebral ischemia after subarachnoid hemorrhage Stroke 20 11 1511 5 2815186 1:STN:280:DyaK3c%2FltVeksg%3D%3D
14. T Murphy R Dhar A Axelrod J Corry E Russel M Diringer 2008 Conivaptan for the correction of hyponatremia in the neurocritical care unit Neurocrit Care 8 196